EUVIMEDEUVIMED entdecken
Open Access

COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022

Randy Yee, David Carranza, Christine Kim, James Phillip Trinidad, James L Tobias, Roma Bhatkoti, Sachiko Kuwabara

Emerging Infectious Diseases · 2024

DOI: 10.3201/eid3005.230357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2024. Verfasst von Randy Yee und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Health Services Accessibility. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During December 11, 2020-March 29, 2022, the US government delivered ≈700 million doses of COVID-19 vaccine to vaccination sites, resulting in vaccination of ≈75% of US adults during that period. We evaluated accessibility of vaccination sites. Sites were accessible by walking within 15 minutes by 46.6% of persons, 30 minutes by 74.8%, 45 minutes by 82.8%, and 60 minutes by 86.7%. When limited to populations in counties with high social vulnerability, accessibility by walking was 55.3%, 81.1%, 86.7%, and 89.4%, respectively. By driving, lowest accessibility was 96.5% at 15 minutes. For urban/rural categories, the 15-minute walking accessibility between noncore and large central metropolitan areas ranged from 27.2% to 65.1%; driving accessibility was 79.9% to 99.5%. By 30 minutes driving accessibility for all urban/rural categories was >95.9%. Walking time variations across jurisdictions and between urban/rural areas indicate that potential gains could have been made by improving walkability or making transportation more readily available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesSARS-CoV-2Health Services AccessibilityVaccinationHumansUnited StatesRural PopulationWalkingUrban Population

Stichwörter der Autor:innen

2019 novel coronavirus diseaseCOVID-19GIS analysisSARS-CoV-2United Statesaccessibilitycoronavirus diseaserespiratory infectionssevere acute respiratory syndrome coronavirus 2social vulnerability indexvaccination sitesvaccineviruseszoonoses

Substanzen

COVID-19 Vaccines

Zitieren

APA

Yee, R., Carranza, D., Kim, C., Trinidad, J. P., Tobias, J. L., Bhatkoti, R., & Kuwabara, S. (2024). COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022. Emerging Infectious Diseases. https://doi.org/10.3201/eid3005.230357

Vancouver

Yee R, Carranza D, Kim C, Trinidad JP, Tobias JL, Bhatkoti R, et al. COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022. Emerging Infectious Diseases. 2024. doi:10.3201/eid3005.230357

BibTeX
@article{Yee2024,
  author = {Yee, Randy and Carranza, David and Kim, Christine and Trinidad, James Phillip and Tobias, James L and Bhatkoti, Roma and Kuwabara, Sachiko},
  title = {COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022},
  journal = {Emerging Infectious Diseases},
  year = {2024},
  doi = {10.3201/eid3005.230357}
}
Kostenlos starten →